Skip to main content

Advertisement

Log in

Progress of oral care and reduction of oral mucositis—a pilot study in a hematopoietic stem cell transplantation ward

  • Short Communication
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Oral mucositis is a common symptomatic complication associated with hematopoietic stem cell transplantation (HCT). We use simple strategies aimed to reduce oral mucositis by keeping the oral cavity clean and moist. Here, we report on the progress of oral care and the changes in the degree of oral mucositis. The purpose of this pilot study is to evaluate the effects of our strategies on the prevalence and the severity of oral mucositis.

Methods

Fifty-three consecutive patients from 2003 to 2006 administered with conventional allogeneic HCT were enrolled in this study. The degree of oral mucositis was evaluated daily in all patients. Our oral care program was divided into two periods: “examination and trial period (2003 and 2004)” and “intensive oral care period (2005 and 2006).” In the latter, an oral care regimen was carried out systematically by a multidisciplinary team.

Results

Using our oral care strategies, the prevalence of ulcerative oral mucositis was decreased significantly. The rate was reduced from 76% (10 of 13) of patients with ulcerative oral mucositis in 2003 to only 20% (3 of 15) in 2006.

Conclusions

Our pilot study suggests that oral mucositis in HCT patients can be alleviated by simple strategies aimed at keeping the oral cavity clean and moist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4:227–284

    Article  Google Scholar 

  2. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205

    PubMed  CAS  Google Scholar 

  3. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33–39

    PubMed  CAS  Google Scholar 

  4. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831

    Article  PubMed  CAS  Google Scholar 

  5. Bensinger W, Schubert M, Ang KK, Brizel D, Brown E, Eilers JG, Elting L, Mittal BB, Schattner MA, Spielberger R, Treister NS, Trotti AM 3rd (2008) NCCN task force report. Prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 6(Suppl 1):S1–S21

    PubMed  CAS  Google Scholar 

  6. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730

    Article  PubMed  Google Scholar 

  7. US National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.ppd. Accessed 4 January 2010

  8. Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M (1994) Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 30B:93–97

    Article  PubMed  CAS  Google Scholar 

  9. Sugiura Y, Soga Y, Tanimoto I, Kokeguchi S, Nishide S, Kono K, Takahashi K, Fujii N, Ishimaru F, Tanimoto M, Yamabe K, Tsutani S, Nishimura F, Takashiba S (2008) Antimicrobial effects of the saliva substitute, Oralbalance, against microorganisms from oral mucosa in the hematopoietic cell transplantation period. Support Care Cancer 16:421–424

    Article  PubMed  Google Scholar 

  10. Ransier A, Epstein JB, Lunn R, Spinelli J (1995) A combined analysis of a toothbrush, foam brush, and a chlorhexidine-soaked foam brush in maintaining oral hygiene. Cancer Nurs 18:393–396

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was partially conducted as the education curriculum, Practice in Dental Sciences, in Okayama University Dental School. We thank Ms. Yuka Oka, a student at Okayama University Dental School, for data analysis.

This study was partly supported by a Grant-in-Aid for Young Scientists (Start-up #20890138 and B #22791836 to YS) from the Japan Society for the Promotion of Science and an unrestricted grant from the Scholarship Fund donated by the T&K Corporation, Tokyo, Japan (to ST). T&K Corporation is the exclusive agent of Biotene® products, including Oralbalance® (Laclede, Rancho Dominguez, CA), in Japan. Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences approved this private scholarship fund.

Conflicts of Interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shogo Takashiba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soga, Y., Sugiura, Y., Takahashi, K. et al. Progress of oral care and reduction of oral mucositis—a pilot study in a hematopoietic stem cell transplantation ward. Support Care Cancer 19, 303–307 (2011). https://doi.org/10.1007/s00520-010-1002-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-010-1002-y

Keywords

Navigation